InsiderClue
Insiders · Profile

Hall Ashley

Chief Development Officer at OnKure Therapeutics. Filing since 28 Aug 2023. CIK 0001801842

Company
Date
Role
Action
Shares
Amount
Of holding
OKUR OnKure Therapeutics, Inc.
28 Aug 2023
Chief Development Officer
Sold at will
15,625
$98.06K
28.3%
1 decision on file.